{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T10:52:57Z","timestamp":1773485577369,"version":"3.50.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Netw Model Anal Health Inform Bioinforma"],"DOI":"10.1007\/s13721-026-00779-3","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T10:09:20Z","timestamp":1773482960000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Microbial metabolites as promising alternatives to empagliflozin for type 2 diabetes management"],"prefix":"10.1007","volume":"15","author":[{"given":"Amzadur Rahman","family":"Rakib","sequence":"first","affiliation":[]},{"given":"Tahmina Akter","family":"Bristi","sequence":"additional","affiliation":[]},{"given":"Jannatul","family":"Shifa","sequence":"additional","affiliation":[]},{"given":"Sabikunnahar","family":"Surovi","sequence":"additional","affiliation":[]},{"given":"Mrittika","family":"Banik","sequence":"additional","affiliation":[]},{"given":"Anika","family":"Bushra","sequence":"additional","affiliation":[]},{"given":"Tasmia","family":"Sultana","sequence":"additional","affiliation":[]},{"given":"Shanjida Akter","family":"Joyoti","sequence":"additional","affiliation":[]},{"given":"Md. Toslim","family":"Mahmud","sequence":"additional","affiliation":[]},{"given":"Firoz","family":"Ahmed","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0936-6653","authenticated-orcid":false,"given":"Noimul Hasan","family":"Siddiquee","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2026,3,14]]},"reference":[{"key":"779_CR1","doi-asserted-by":"publisher","unstructured":"Abdel-Razek AS, El-Naggar ME, Allam A, Morsy OM, Othman SI (2020) Microbial Natural Products in Drug Discovery. Processes 2020 8(4):470. https:\/\/doi.org\/10.3390\/PR8040470","DOI":"10.3390\/PR8040470"},{"issue":"5","key":"779_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/bib\/bbab098","volume":"22","author":"F Ahammad","year":"2021","unstructured":"Ahammad F, Alam R, Mahmud R, Akhter S, Talukder EK, Tonmoy AM, Fahim S, Al-Ghamdi K, Samad A, Qadri I (2021) Pharmacoinformatics and molecular dynamics simulation-based phytochemical screening of neem plant (Azadiractha indica) against human cancer by targeting MCM7 protein. Brief Bioinform 22(5):1\u201315. https:\/\/doi.org\/10.1093\/bib\/bbab098","journal-title":"Brief Bioinform"},{"key":"779_CR4","doi-asserted-by":"publisher","unstructured":"Alam S, Sarker MMR, Sultana TN, Chowdhury MNR, Rashid MA, Chaity NI, Zhao C, Xiao J, Hafez EE, Khan SA, Mohamed IN (2022) Antidiabetic Phytochemicals From Medicinal Plants: Prospective Candidates for New Drug Discovery and Development. In Frontiers in Endocrinology. Front Media S A 13. https:\/\/doi.org\/10.3389\/fendo.2022.800714","DOI":"10.3389\/fendo.2022.800714"},{"issue":"4","key":"779_CR3","doi-asserted-by":"publisher","first-page":"e521","DOI":"10.5001\/omj.2023.128","volume":"38","author":"S Al Rashid","year":"2023","unstructured":"Al Rashid S, Elango P, Rahman SZ (2023) SGLT2 Inhibitors for Cardioprotection. Oman Med J 38(4):e521. https:\/\/doi.org\/10.5001\/omj.2023.128","journal-title":"Oman Med J"},{"issue":"12","key":"779_CR5","doi-asserted-by":"publisher","first-page":"e5646","DOI":"10.1590\/1414-431X20165646","volume":"49","author":"EL Andrade","year":"2016","unstructured":"Andrade EL, Bento AF, Cavalli J, Oliveira SK, Schwanke RC, Siqueira JM, Freitas CS, Marcon R, Calixto JB (2016) Non-clinical studies in the process of new drug development - Part II: Good laboratory practice, metabolism, pharmacokinetics, safety and dose translation to clinical studies. Brazilian J Med Biol Res = Revista Brasileira de Pesquisas Medicas e Biologicas 49(12):e5646. https:\/\/doi.org\/10.1590\/1414-431X20165646","journal-title":"Brazilian J Med Biol Res = Revista Brasileira de Pesquisas Medicas e Biologicas"},{"key":"779_CR6","doi-asserted-by":"publisher","DOI":"10.1145\/1188455.1188457","author":"R Armstrong","year":"2006","unstructured":"Armstrong R (2006) Compframe: Developement of component frameworks for high performance computing. Proc 2006 ACM\/IEEE Conf Supercomputing SC\u201906. https:\/\/doi.org\/10.1145\/1188455.1188457","journal-title":"Proc 2006 ACM\/IEEE Conf Supercomputing SC\u201906"},{"issue":"9","key":"779_CR7","doi-asserted-by":"publisher","first-page":"103753","DOI":"10.1016\/j.sjbs.2023.103753","volume":"30","author":"ZK Bagewadi","year":"2023","unstructured":"Bagewadi ZK, Khan Y, Gangadharappa TM, Kamalapurkar B, Shamsudeen AM, S., Yaraguppi DA (2023) Molecular dynamics and simulation analysis against superoxide dismutase (SOD) target of Micrococcus luteus with secondary metabolites from Bacillus licheniformis recognized by genome mining approach. Saudi J Biol Sci 30(9):103753. https:\/\/doi.org\/10.1016\/j.sjbs.2023.103753","journal-title":"Saudi J Biol Sci"},{"key":"779_CR8","doi-asserted-by":"publisher","unstructured":"Balogh DB, Wagner LJ, Fekete A (2023) An Overview of the Cardioprotective Effects of Novel Antidiabetic Classes: Focus on Inflammation, Oxidative Stress, and Fibrosis. Int J Mol Sci 2023 24(9). https:\/\/doi.org\/10.3390\/ijms24097789","DOI":"10.3390\/ijms24097789"},{"issue":"W1","key":"779_CR9","doi-asserted-by":"publisher","first-page":"W513","DOI":"10.1093\/nar\/gkae303","volume":"52","author":"P Banerjee","year":"2024","unstructured":"Banerjee P, Kemmler E, Dunkel M, Preissner R (2024) ProTox 3.0: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res 52(W1):W513\u2013W520. https:\/\/doi.org\/10.1093\/nar\/gkae303","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"779_CR10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.4236\/jdm.2019.93009","volume":"9","author":"C-Y Chang","year":"2019","unstructured":"Chang C-Y, Ho Y, Lin S-J, Liu H-L, Chang C-Y, Ho Y, Lin S-J, Liu H-L (2019) Discovery of Novel N-Glycoside and Non-Glycoside hSGLT2 Inhibitors for the Treatment of Type 2 Diabetes Mellitus. J Diabetes Mellitus 9(3):77\u2013104. https:\/\/doi.org\/10.4236\/jdm.2019.93009","journal-title":"J Diabetes Mellitus"},{"issue":"3","key":"779_CR11","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1016\/J.DSX.2019.04.035","volume":"13","author":"G Chawla","year":"2019","unstructured":"Chawla G, Chaudhary KK (2019) A complete review of empagliflozin: Most specific and potent SGLT2 inhibitor used for the treatment of type 2 diabetes mellitus. Diabetes Metabolic Syndrome 13(3):2001\u20132008. https:\/\/doi.org\/10.1016\/J.DSX.2019.04.035","journal-title":"Diabetes Metabolic Syndrome"},{"key":"779_CR12","doi-asserted-by":"publisher","unstructured":"Chen Z, Tan K, Shi Y, Liu M, Yi L, Chen T, Bai Y (2026) Computational Discovery of Novel SGLT2 Inhibitors from Eight Selected Medicine Food Homology Herbs Using a Multi-Stage Virtual Screening Pipeline. Pharmaceuticals 2026 19(2):246. https:\/\/doi.org\/10.3390\/ph19020246","DOI":"10.3390\/ph19020246"},{"issue":"12","key":"779_CR13","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1111\/dom.12572","volume":"17","author":"R Chilton","year":"2015","unstructured":"Chilton R, Tikkanen I, Cannon CP, Crowe S, Woerle HJ, Broedl UC, Johansen OE (2015) Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes. Diabetes Obes Metabolism 17(12):1180\u20131193. https:\/\/doi.org\/10.1111\/dom.12572","journal-title":"Diabetes Obes Metabolism"},{"issue":"5","key":"779_CR14","doi-asserted-by":"publisher","first-page":"e001007","DOI":"10.1136\/bmjopen-2012-001007","volume":"2","author":"C Clar","year":"2012","unstructured":"Clar C, Gill JA, Court R, Waugh N (2012) Systematic review of SGLT2 receptor inhibitors in dual or triple therapy in type 2 diabetes. BMJ Open 2(5):e001007. https:\/\/doi.org\/10.1136\/bmjopen-2012-001007","journal-title":"BMJ Open"},{"issue":"4","key":"779_CR15","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2143\/ACB.3349","volume":"68","author":"J Cuypers","year":"2013","unstructured":"Cuypers J, Mathieu C, Benhalima K (2013) SGLT2-inhibitors: A novel class for the treatment of type 2 diabetes introduction of SGLT2-inhibitors in clinical practice. Acta Clin Belg 68(4):287\u2013293. https:\/\/doi.org\/10.2143\/ACB.3349","journal-title":"Acta Clin Belg"},{"issue":"1","key":"779_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/SREP42717;TECHMETA","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7(1):1\u201313. https:\/\/doi.org\/10.1038\/SREP42717;TECHMETA","journal-title":"Sci Rep"},{"issue":"6","key":"779_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3810\/pgm.2014.10.2819","volume":"126","author":"JA Davidson","year":"2014","unstructured":"Davidson JA, Kuritzky L (2014) Sodium glucose co-transporter 2 inhibitors and their mechanism for improving glycemia in patients with type 2 diabetes. Postgrad Med 126(6):33\u201348. https:\/\/doi.org\/10.3810\/pgm.2014.10.2819","journal-title":"Postgrad Med"},{"issue":"5","key":"779_CR18","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/J.BMCL.2014.01.037","volume":"24","author":"J Deng","year":"2014","unstructured":"Deng J, Lu C, Li S, Hao H, Li Z, Zhu J, Li Y, Shen Y (2014) p-Terphenyl O-\u03b2-glucuronides, DNA topoisomerase inhibitors from Streptomyces sp. LZ35\u2206gdmAI Bioorg Med Chem Lett 24(5):1362\u20131365. https:\/\/doi.org\/10.1016\/J.BMCL.2014.01.037","journal-title":"LZ35\u2206gdmAI Bioorg Med Chem Lett"},{"key":"779_CR19","unstructured":"Diabetes. (n.d.). Retrieved October 11 (2024) from https:\/\/www.who.int\/health-topics\/diabetes?gad_source=1&gclid=CjwKCAjw9p24BhB_EiwA8ID5BjJNAnifUXauYb6sZAaVj4D_CmBPU0pKDdBYrn01tQPichoGfgHnERoC9_sQAvD_BwE#tab=tab_1"},{"key":"779_CR20","doi-asserted-by":"publisher","unstructured":"Dong L, Feng R, Bi J, Shen S, Lu H, Zhang J (2018a) Insight into the interaction mechanism of human SGLT2 with its inhibitors: 3D-QSAR studies, homology modeling, and molecular docking and molecular dynamics simulations. J Mol Model 24(4). https:\/\/doi.org\/10.1007\/s00894-018-3582-2","DOI":"10.1007\/s00894-018-3582-2"},{"issue":"4","key":"779_CR21","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s00894-018-3582-2","volume":"24","author":"L Dong","year":"2018","unstructured":"Dong L, Feng R, Bi J, Shen S, Lu H, Zhang J (2018b) Insight into the interaction mechanism of human SGLT2 with its inhibitors: 3D-QSAR studies, homology modeling, and molecular docking and molecular dynamics simulations. J Mol Model 2018 24(4):86. https:\/\/doi.org\/10.1007\/s00894-018-3582-2","journal-title":"J Mol Model 2018"},{"issue":"1","key":"779_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/dmrr.532","volume":"21","author":"JRL Ehrenkranz","year":"2005","unstructured":"Ehrenkranz JRL, Lewis NG, Kahn CR, Roth J (2005) Phlorizin: A review. Diab\/Metab Res Rev 21(1):31\u201338. https:\/\/doi.org\/10.1002\/dmrr.532","journal-title":"Diab\/Metab Res Rev"},{"issue":"2","key":"779_CR23","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa2204233","volume":"388","author":"Empagliflozin in Patients with Chronic Kidney Disease","year":"2023","unstructured":"Empagliflozin in Patients with Chronic Kidney Disease (2023) N Engl J Med 388(2):117\u2013127. https:\/\/doi.org\/10.1056\/NEJMoa2204233","journal-title":"N Engl J Med"},{"issue":"1","key":"779_CR24","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s40200-016-0275-1","volume":"2016 15","author":"M Ghodsi","year":"2016","unstructured":"Ghodsi M, larijani B, Keshtkar AA, Nasli-Esfahani E, Alatab S, Mohajeri-Tehrani MR (2016) Mechanisms involved in altered bone metabolism in diabetes: a narrative review. J Diabetes Metabolic Disorders 2016 15(1):52. https:\/\/doi.org\/10.1186\/s40200-016-0275-1","journal-title":"J Diabetes Metabolic Disorders"},{"issue":"7","key":"779_CR25","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1021\/JM030644S\/SUPPL_FILE\/JM030644S_S.PDF","volume":"47","author":"TA Halgren","year":"2004","unstructured":"Halgren TA, Murphy RB, Friesner RA, Beard HS, Frye LL, Pollard WT, Banks JL (2004) Glide: A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database Screening. J Med Chem 47(7):1750\u20131759. https:\/\/doi.org\/10.1021\/JM030644S\/SUPPL_FILE\/JM030644S_S.PDF","journal-title":"J Med Chem"},{"issue":"1","key":"779_CR26","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41594-023-01134-0","volume":"2023 31","author":"M Hiraizumi","year":"2023","unstructured":"Hiraizumi M, Akashi T, Murasaki K, Kishida H, Kumanomidou T, Torimoto N, Nureki O, Miyaguchi I (2023) Transport and inhibition mechanism of the human SGLT2\u2013MAP17 glucose transporter. Nat Struct Mol Biol 2023 31(1):159\u2013169. https:\/\/doi.org\/10.1038\/s41594-023-01134-0","journal-title":"Nat Struct Mol Biol"},{"issue":"6","key":"779_CR27","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1002\/HLCA.200590118","volume":"88","author":"B Irlinger","year":"2005","unstructured":"Irlinger B, Bartsch A, Kr\u00e4mer HJ, Mayser P, Steglich W (2005) New tryptophan metabolites from cultures of the lipophilic yeast Malassezia furfur. Helv Chim Acta 88(6):1472\u20131485. https:\/\/doi.org\/10.1002\/HLCA.200590118","journal-title":"Helv Chim Acta"},{"key":"779_CR29","unstructured":"Jardiance (2025) Uses, Taking, Side Effects, Warnings - Medicine.com. (n.d.). Retrieved January 24, from https:\/\/www.medicine.com\/drug\/jardiance"},{"key":"779_CR28","unstructured":"Jardiance, Uses Dosage, Side Effects & Warnings - Drugs.com. (n.d.). https:\/\/www.drugs.com\/jardiance.html"},{"issue":"8","key":"779_CR30","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1021\/acs.jctc.3c00044","volume":"19","author":"RC Johnston","year":"2023","unstructured":"Johnston RC, Yao K, Kaplan Z, Chelliah M, Leswing K, Seekins S, Watts S, Calkins D, Chief Elk J, Jerome SV, Repasky MP, Shelley JC (2023) Epik: pKa and Protonation State Prediction through Machine Learning. J Chem Theory Comput 19(8):2380\u20132388. https:\/\/doi.org\/10.1021\/acs.jctc.3c00044","journal-title":"J Chem Theory Comput"},{"issue":"7","key":"779_CR31","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/S00705-003-0102-0\/METRICS","volume":"148","author":"PD Kara","year":"2003","unstructured":"Kara PD, Afonso CL, Wallace DB, Kutish GF, Abolnik C, Lu Z, Vreede FT, Taljaard LCF, Zsak A, Viljoen GJ, Rock DL (2003) Comparative sequence analysis of the South African vaccine strain and two virulent field isolates of Lumpy skin disease virus. Arch Virol 148(7):1335\u20131356. https:\/\/doi.org\/10.1007\/S00705-003-0102-0\/METRICS","journal-title":"Arch Virol"},{"issue":"2","key":"779_CR32","doi-asserted-by":"publisher","first-page":"184","DOI":"10.25135\/acg.oc.122.2203.2397","volume":"15","author":"SMA Kawsar","year":"2022","unstructured":"Kawsar SMA, Kumer A, Munia NS, Hosen MA, Chakma U, Akash S (2022) Chemical descriptors, PASS, molecular docking, molecular dynamics and ADMET predictions of glucopyranoside derivatives as inhibitors to bacteria and fungi growth. Org Commun 15(2):184\u2013203. https:\/\/doi.org\/10.25135\/acg.oc.122.2203.2397","journal-title":"Org Commun"},{"issue":"15","key":"779_CR33","doi-asserted-by":"publisher","first-page":"5799","DOI":"10.1080\/07391102.2020.1787226","volume":"39","author":"S Krupanidhi","year":"2021","unstructured":"Krupanidhi S, Peele A, Venkateswarulu K, Ayyagari TC, Bobby VSN, Babu MJ, Venkata Narayana D, A., Aishwarya G (2021) Screening of phytochemical compounds of Tinospora cordifolia for their inhibitory activity on SARS-CoV-2: an in silico study. J Biomol Struct Dynamics 39(15):5799\u20135803. https:\/\/doi.org\/10.1080\/07391102.2020.1787226","journal-title":"J Biomol Struct Dynamics"},{"issue":"08","key":"779_CR34","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.6026\/973206300212459","volume":"21","author":"S Kumar","year":"2025","unstructured":"Kumar S, Prakash V, Kattimani R, Gupta S, Ravi R, Podder A (2025) Evaluation of cardio-protective effects of a Novel SGLT2 inhibitor beyond glycemic control in preclinical models. Bioinformation 21(08):2459\u20132463. https:\/\/doi.org\/10.6026\/973206300212459","journal-title":"Bioinformation"},{"issue":"4","key":"779_CR35","doi-asserted-by":"publisher","first-page":"405","DOI":"10.2174\/1573399812666160613113556","volume":"13","author":"MJ Levine","year":"2016","unstructured":"Levine MJ (2016) Empagliflozin for Type 2 Diabetes Mellitus: An Overview of Phase 3 Clinical Trials. Curr Diabetes Rev 13(4):405\u2013423. https:\/\/doi.org\/10.2174\/1573399812666160613113556","journal-title":"Curr Diabetes Rev"},{"issue":"1","key":"779_CR36","doi-asserted-by":"publisher","first-page":"31411","DOI":"10.1038\/s41598-025-15232-0","volume":"15","author":"D Liu","year":"2025","unstructured":"Liu D, Yu L, Cao ML, Wang S, Zhou N, Ren YR (2025) Screening of SGLT2 inhibitors based on virtual screening and cellular experiments. Sci Rep 2025 15(1):31411. https:\/\/doi.org\/10.1038\/s41598-025-15232-0","journal-title":"Sci Rep 2025"},{"key":"779_CR37","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.2147\/JIR.S309427","volume":"14","author":"Y Liu","year":"2021","unstructured":"Liu Y, Wu M, Xu B, Kang L (2021) Empagliflozin alleviates atherosclerosis progression by inhibiting inflammation and sympathetic activity in a normoglycemic mouse model. J Inflamm Res 14:2277\u20132287. https:\/\/doi.org\/10.2147\/JIR.S309427","journal-title":"J Inflamm Res"},{"issue":"7","key":"779_CR38","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","volume":"17","author":"C Lu","year":"2021","unstructured":"Lu C, Wu C, Ghoreishi D, Chen W, Wang L, Damm W, Ross GA, Dahlgren MK, Russell E, Von Bargen CD, Abel R, Friesner RA, Harder ED (2021) OPLS4: Improving Force Field Accuracy on Challenging Regimes of Chemical Space. J Chem Theory Comput 17(7):4291\u20134300. https:\/\/doi.org\/10.1021\/acs.jctc.1c00302","journal-title":"J Chem Theory Comput"},{"issue":"3","key":"779_CR39","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"G Madhavi Sastry","year":"2013","unstructured":"Madhavi Sastry G, Adzhigirey M, Day T, Annabhimoju R, Sherman W (2013) Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des 27(3):221\u2013234. https:\/\/doi.org\/10.1007\/s10822-013-9644-8","journal-title":"J Comput Aided Mol Des"},{"issue":"10","key":"779_CR40","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1002\/ptr.6421","volume":"33","author":"R Moradi-Marjaneh","year":"2019","unstructured":"Moradi-Marjaneh R, Paseban M, Sahebkar A (2019) Natural products with SGLT2 inhibitory activity: Possibilities of application for the treatment of diabetes. Phytother Res 33(10):2518\u20132530. https:\/\/doi.org\/10.1002\/ptr.6421","journal-title":"Phytother Res"},{"issue":"7892","key":"779_CR41","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41586-021-04212-9","volume":"601","author":"Y Niu","year":"2022","unstructured":"Niu Y, Liu R, Guan C, Zhang Y, Chen Z, Hoerer S, Nar H, Chen L (2022) Structural basis of inhibition of the human SGLT2\u2013MAP17 glucose transporter. Nature 601(7892):280\u2013284. https:\/\/doi.org\/10.1038\/s41586-021-04212-9","journal-title":"Nature"},{"key":"779_CR42","doi-asserted-by":"publisher","unstructured":"Pinzi L, Rastelli G (2019) Molecular docking: Shifting paradigms in drug discovery. Int J Mol Sci 20(18). https:\/\/doi.org\/10.3390\/ijms20184331","DOI":"10.3390\/ijms20184331"},{"issue":"3","key":"779_CR43","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1021\/acs.jctc.8b01026","volume":"15","author":"K Roos","year":"2019","unstructured":"Roos K, Wu C, Damm W, Reboul M, Stevenson JM, Lu C, Dahlgren MK, Mondal S, Chen W, Wang L, Abel R, Friesner RA, Harder ED (2019) OPLS3e: Extending Force Field Coverage for Drug-Like Small Molecules. J Chem Theory Comput 15(3):1863\u20131874. https:\/\/doi.org\/10.1021\/acs.jctc.8b01026","journal-title":"J Chem Theory Comput"},{"key":"779_CR44","doi-asserted-by":"publisher","first-page":"113705","DOI":"10.1016\/j.ejmech.2021.113705","volume":"224","author":"VT Sabe","year":"2021","unstructured":"Sabe VT, Ntombela T, Jhamba LA, Maguire GEM, Govender T, Naicker T, Kruger HG (2021) Current trends in computer aided drug design and a highlight of drugs discovered via computational techniques: A review. Eur J Med Chem 224:113705. https:\/\/doi.org\/10.1016\/j.ejmech.2021.113705","journal-title":"Eur J Med Chem"},{"key":"779_CR45","doi-asserted-by":"publisher","first-page":"108086","DOI":"10.1016\/j.diabres.2020.108086","volume":"162","author":"P Saeedi","year":"2020","unstructured":"Saeedi P, Salpea P, Karuranga S, Petersohn I, Malanda B, Gregg EW, Unwin N, Wild SH, Williams R (2020) Mortality attributable to diabetes in 20\u201379 years old adults, 2019 estimates: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract 162:108086. https:\/\/doi.org\/10.1016\/j.diabres.2020.108086","journal-title":"Diabetes Res Clin Pract"},{"key":"779_CR46","unstructured":"Saroglitazar Magnesium | Indications, Pharmacology, Dosage, Side Effects & other Generic info with Available Brand names in Bangladesh | MedEx. (n.d.). Retrieved January 24, (2025) from https:\/\/medex.com.bd\/generics\/2327\/saroglitazar-magnesium\/en"},{"key":"779_CR47","doi-asserted-by":"publisher","unstructured":"Saurabh S, Sivakumar PM, Perumal V, Khosravi A, Sugumaran A, Prabhawathi V (2020) Molecular Dynamics Simulations in Drug Discovery and Drug Delivery. Eng Mater 275\u2013301. https:\/\/doi.org\/10.1007\/978-3-030-36260-7_10","DOI":"10.1007\/978-3-030-36260-7_10"},{"key":"779_CR48","doi-asserted-by":"publisher","unstructured":"Shridhar Veeresh Pattar, Shakeel Ahamed Adhoni, C. M. K. & S. S. K. (2020). In silico molecular docking studies and MM\/GBSA analysis of coumarin-carbonodithioate hybrid derivatives divulge the anticancer potential against breast cancer. Springer, https:\/\/doi.org\/10.1186\/s43088-020-00059-7","DOI":"10.1186\/s43088-020-00059-7"},{"issue":"February","key":"779_CR49","doi-asserted-by":"publisher","first-page":"101458","DOI":"10.1016\/j.imu.2024.101458","volume":"45","author":"NH Siddiquee","year":"2024","unstructured":"Siddiquee NH, Hossain MI, Talukder MEK, Nirob SAA, Shourav M, Jahan I, Tamanna UHA, Das P, Akter R, Hasan M, Abdullah-Al-Mamun M, Saha O (2024a) In-silico identification of novel natural drug leads against the Ebola virus VP40 protein: A promising approach for developing new antiviral therapeutics. Inf Med Unlocked 45(February):101458. https:\/\/doi.org\/10.1016\/j.imu.2024.101458","journal-title":"Inf Med Unlocked"},{"issue":"4 APRIL","key":"779_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0321902","volume":"20","author":"NH Siddiquee","year":"2025","unstructured":"Siddiquee NH, Joyoti SA, Zaker BB, Eva MA, Nava AI, Mridu NJ, Shawon AA, Rahman S, Chowdhury TJ, Katha SS, Islam MR, Uddin MS (2025) Molecular activity of bioactive phytocompounds for inhibiting host cell attachment and membrane fusion interacting with West Nile Virus envelope glycoprotein. PLoS ONE 20(4 APRIL):1\u201330. https:\/\/doi.org\/10.1371\/journal.pone.0321902","journal-title":"PLoS ONE"},{"issue":"April","key":"779_CR51","doi-asserted-by":"publisher","first-page":"101486","DOI":"10.1016\/j.imu.2024.101486","volume":"47","author":"NH Siddiquee","year":"2024","unstructured":"Siddiquee NH, Malek S, Tanni AA, Mitu IJ, Arpa SH, Hasan MR, Shammi SEJ, Chakma C, Mahinur M, Wajed S, Hossain MI, Aktaruzzaman M, Saha O (2024b) Unveiling the antiviral activity of 2\u2032,3,5,7-Tetrahydroxyflavanone as potential inhibitor of chikungunya virus envelope glycoprotein. Informatics Medicine Unlocked 47(April):101486. https:\/\/doi.org\/10.1016\/j.imu.2024.101486","journal-title":"Informatics Medicine Unlocked"},{"key":"779_CR52","doi-asserted-by":"publisher","unstructured":"Siddiquee NH, Sujan MSI, Dremit TI, Rahat EH, Barman K, Karim M, Nandi C, Akter S, Talukder MEK, Hosen MS, Khaled M, Saha O (2024c) Natural Products in Precision Neurological Disease (Cryptococcal Meningitis): Structure-Based Phytochemical Screening of Glycyrrhiza glabra Plant Against Cryptococcus neoformans Farnesyltransferase (FTase). Chemistry & Biodiversity. https:\/\/doi.org\/10.1002\/CBDV.202401987","DOI":"10.1002\/CBDV.202401987"},{"issue":"May","key":"779_CR53","doi-asserted-by":"publisher","first-page":"101522","DOI":"10.1016\/j.imu.2024.101522","volume":"48","author":"NH Siddiquee","year":"2024","unstructured":"Siddiquee NH, Tanni AA, Sarker N, Sourav SH, Islam L, Mili MA, Akter F, Chandra Roy S, Abdullah-Al-Mamun M, Malek S, Afsari S, Islam MA, Wajed S (2024d) Insights into novel inhibitors intending HCMV protease a computational molecular modelling investigation for antiviral drug repurposing. Inf Med Unlocked 48(May):101522. https:\/\/doi.org\/10.1016\/j.imu.2024.101522","journal-title":"Inf Med Unlocked"},{"issue":"July","key":"779_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fchem.2024.1407331","volume":"12","author":"MEK Talukder","year":"2024","unstructured":"Talukder MEK, Aktaruzzaman M, Siddiquee NH, Islam S, Wani TA, Alkahtani HM, Zargar S, Raihan MO, Rahman MM, Pokhrel S, Ahammad F (2024) Cheminformatics-based identification of phosphorylated RET tyrosine kinase inhibitors for human cancer. Front Chem 12(July):1\u201318. https:\/\/doi.org\/10.3389\/fchem.2024.1407331","journal-title":"Front Chem"},{"key":"779_CR55","doi-asserted-by":"publisher","first-page":"139924","DOI":"10.1016\/J.MOLSTRUC.2024.139924","volume":"1321","author":"MEK Talukder","year":"2025","unstructured":"Talukder MEK, Atif MF, Siddiquee NH, Rahman S, Rafi NI, Israt S, Shahir NF, Islam MT, Samad A, Wani TA, Rahman MM, Ahammad F (2025) Molecular docking, QSAR, and simulation analyses of EGFR-targeting phytochemicals in non-small cell lung cancer. J Mol Struct 1321:139924. https:\/\/doi.org\/10.1016\/J.MOLSTRUC.2024.139924","journal-title":"J Mol Struct"},{"issue":"16","key":"779_CR56","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.3390\/IJERPH16162965","volume":"16","author":"A Tentolouris","year":"2019","unstructured":"Tentolouris A, Vlachakis P, Tzeravini E, Eleftheriadou I, Tentolouris N (2019) SGLT2 Inhibitors: A Review of Their Antidiabetic and Cardioprotective Effects. Int J Environ Res Public Health 16(16):2965. https:\/\/doi.org\/10.3390\/IJERPH16162965","journal-title":"Int J Environ Res Public Health"},{"key":"779_CR57","unstructured":"Type 2 Diabetes | International Diabetes Federation (n.d.). Retrieved April 25 (2025) from https:\/\/idf.org\/about-diabetes\/types-of-diabetes\/type-2\/"},{"issue":"2","key":"779_CR58","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00125-016-4157-3","volume":"60","author":"V Vallon","year":"2017","unstructured":"Vallon V, Thomson SC (2017) Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition. Diabetologia 60(2):215\u2013225. https:\/\/doi.org\/10.1007\/s00125-016-4157-3","journal-title":"Diabetologia"},{"key":"779_CR59","doi-asserted-by":"publisher","unstructured":"Webber S (2013) International Diabetes Federation. In Diabetes Research and Clinical Practice 102(2). https:\/\/doi.org\/10.1016\/j.diabres.2013.10.013","DOI":"10.1016\/j.diabres.2013.10.013"},{"issue":"3","key":"779_CR60","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/J.DIABRES.2011.10.029","volume":"94","author":"DR Whiting","year":"2011","unstructured":"Whiting DR, Guariguata L, Weil C, Shaw J (2011) IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94(3):311\u2013321. https:\/\/doi.org\/10.1016\/J.DIABRES.2011.10.029","journal-title":"Diabetes Res Clin Pract"},{"key":"779_CR61","first-page":"11","volume":"978","author":"WHO Global Report","year":"2016","unstructured":"WHO Global Report (2016) Global Report on Diabetes. Isbn 978:11. http:\/\/www.who.int\/about\/licensing\/copyright_form\/index.html%0A","journal-title":"Isbn"},{"issue":"5","key":"779_CR62","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.2337\/DIACARE.27.5.1047","volume":"27","author":"S Wild","year":"2004","unstructured":"Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27(5):1047\u20131053. https:\/\/doi.org\/10.2337\/DIACARE.27.5.1047","journal-title":"Diabetes Care"},{"issue":"12","key":"779_CR63","doi-asserted-by":"publisher","first-page":"16425","DOI":"10.18632\/aging.203165","volume":"13","author":"B Wu","year":"2021","unstructured":"Wu B, Yang W, Fu Z, Xie H, Guo Z, Liu D, Ge J, Zhong S, Liu L, Liu J, Zhu D (2021) Selected Using Bioinformatics and Molecular Docking Analyses, PHA-793887 is Effective Against Osteosarcoma. Aging 13(12):16425\u201316444. https:\/\/doi.org\/10.18632\/aging.203165","journal-title":"Aging"},{"key":"779_CR64","doi-asserted-by":"publisher","first-page":"105522","DOI":"10.1016\/j.ejps.2020.105522","volume":"155","author":"M Yadav","year":"2020","unstructured":"Yadav M, Dhagat S, Eswari JS (2020) Emerging strategies on in silico drug development against COVID-19: challenges and opportunities. Eur J Pharm Sci 155:105522. https:\/\/doi.org\/10.1016\/j.ejps.2020.105522","journal-title":"Eur J Pharm Sci"},{"key":"779_CR65","doi-asserted-by":"publisher","unstructured":"Yaws CL, Leh ASY (2009) Radius of Gyration-Organic Compounds. Thermophysical Prop Chemicals Hydrocarbons 661\u2013668. https:\/\/doi.org\/10.1016\/B978-081551596-8.50022-5","DOI":"10.1016\/B978-081551596-8.50022-5"},{"issue":"3","key":"779_CR66","doi-asserted-by":"publisher","first-page":"304","DOI":"10.2174\/15734064113096660051","volume":"10","author":"L Zhang","year":"2014","unstructured":"Zhang L, Wang Y, Xu H, Shi Y, Liu B, Wei Q, Xu W, Tang L, Wang J, Zhao G (2014) Discovery of 6-Deoxydapagliflozin as a Highly Potent Sodium-dependent Glucose Cotransporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes. Med Chem 10(3):304\u2013317. https:\/\/doi.org\/10.2174\/15734064113096660051","journal-title":"Med Chem"}],"container-title":["Network Modeling Analysis in Health Informatics and Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13721-026-00779-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13721-026-00779-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13721-026-00779-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T10:09:21Z","timestamp":1773482961000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13721-026-00779-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,14]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["779"],"URL":"https:\/\/doi.org\/10.1007\/s13721-026-00779-3","relation":{},"ISSN":["2192-6670"],"issn-type":[{"value":"2192-6670","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,14]]},"assertion":[{"value":"21 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author(s) declared no potential conflicts of interest concerning the research, authorship, and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"conflicts of interest"}},{"value":"No animal or human model is used in this research study. So, no ethical statement is applicable to this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}],"article-number":"90"}}